Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

Laboratory Report

Patient
Name: Berrè, Patrizio
DOB: 21-FEB-1949 (Age: 77)
Gender: male
Address:
Via Bossi, 62
31040 Fanzolo (Italy)
ID: 3822-672758-4 (ECI)
Report
Date: 16-JUN-2021
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Ospedale Vecchio di Montebelluna
Via Sant'Andrea nan
31044 Montebelluna (Italy)
Specimen
Collected: 15-JUN-2021

Chemistry

Test 16-JUN-2021 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.9 4.8 - 5.9 %
Glucose [Mass/volume] in Blood 70.4 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 18.6 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 1.0 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.9 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 140.6 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 3.9 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 103.8 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 26.7 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 207.7 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 126.0 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 131.7 H 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 50.8 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All basic metabolic and glycemic parameters are within normal limits. However, total cholesterol and LDL cholesterol are elevated, indicating increased cardiovascular risk. Recommend dietary modification, lifestyle changes, and clinical follow-up for lipid management. No evidence of renal or electrolyte disturbances.